OverviewSuggest Edit

Accuray is a radiation oncology company that develops, manufactures, sells, and supports precise tumor treatment solutions. The company delivers advanced treatments, including stereotactic radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. Its proprietary products, the CyberKnife, TomoTherapy, and Radixact systems, are capable of treating all standard radiation therapy indications including breast, prostate, lung, and head and neck cancers.

HQSunnyvale, CA, US
Employee Ratings4
Overall CultureD-

Latest Updates

Employees (est.) (Jun 2020)932(-1%)
Job Openings126
Revenue (FY, 2020)$382.9 M(-8%)
Share Price (Jul 2021)$4.2
Cybersecurity ratingCMore

Key People/Management at Accuray

Joshua Levine

Joshua Levine

President and Chief Executive Officer, Director
Suzanne Winter

Suzanne Winter

Chief Commercial Officer and Senior Vice President, R&D
Shig Hamamatsu

Shig Hamamatsu

Senior Vice President, Chief Financial Officer
Scott Chapman

Scott Chapman

Senior Vice President, Global Service
Jesse Chew

Jesse Chew

Senior Vice President, General Counsel and Corporate Secretary
Byron C. Scott

Byron C. Scott

Independent Director
Show more

Accuray Office Locations

Accuray has offices in Sunnyvale, Madison, Chengdu, Hong Kong and in 2 other locations
Sunnyvale, CA, US (HQ)
1310 Chesapeake Terrace
Madison, WI, US
1240 Deming Way
Chengdu, CN
No. 8, Kexin Road, Hi-Tech Zone (West Area)
Hong Kong, HK
Units 910-11, Ocean Centre, Harbour City, 5 Canton Road
Tokyo, JP
2-2-1 Otemachi, Chiyoda-ku
Morges, CH
Route de la Longeraie 9
Show all (6)

Accuray Financials and Metrics

Accuray Revenue

Embed Graph
View revenue for all periods
Accuray's revenue was reported to be $382.93 m in FY, 2020

Revenue (Q3, 2021)


Gross profit (Q3, 2021)


Gross profit margin (Q3, 2021), %


Net income (Q3, 2021)


EBIT (Q3, 2021)


Market capitalization (22-Jul-2021)


Closing stock price (22-Jul-2021)


Cash (31-Mar-2021)



Accuray's current market capitalization is $375.1 m.
USDFY, 2017FY, 2018FY, 2019FY, 2020



Revenue growth, %


Cost of goods sold


Gross profit

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income


Depreciation and Amortization




Accounts Payable

USDQ1, 2017


3.3 x


0.4 x

Financial Leverage

7.9 x
Show all financial metrics

Accuray Operating Metrics

Accuray's Backlog was reported to be $495.6m in FY, 2019.
FY, 2017FY, 2018FY, 2019


$452.85 k$478.48 m$495.63 m

Net Orders

226.56 m209.53 m218.26 m

Patents Issued


Patent Applications

Show all operating metrics

Accuray Acquisitions / Subsidiaries

Company NameDateDeal Size
Morphormics, Inc.July 17, 2012$5.7 m
TomoTherapy IncorporatedMarch 07, 2011$277 m
Accuray Accelerator Technology (Chengdu) Company Limited
Accuray Asia Ltd.
Accuray Belgium BVBA
Accuray Brasil Comércio
Accuray Cayman Islands
Accuray Europe SAS
Accuray International SARL
Accuray Italy S.R.L
Show more

Accuray Revenue Breakdown

Embed Graph

Accuray revenue breakdown by business segment: 47.0% from Products and 53.0% from Services

Accuray revenue breakdown by geographic segment: 16.8% from Japan, 15.2% from Asia Pacific, 35.6% from Europe, Middle East, India and Africa and 32.4% from Americas

Accuray Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Accuray Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset


out of 100

CSRHub logo

Accuray Online and Social Media Presence

Embed Graph

Accuray Company Culture

  • Overall Culture



  • CEO Rating



  • Compensation



Learn more on Comparably

Accuray News and Updates

Hong Kong Sanatorium & Hospital Transforms Cancer Care in Asia with Treatment of First Patient Using the Accuray Radixact® System and ClearRT™ Helical Fan-Beam kVCT Imaging

SUNNYVALE, Calif., July 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at Hong Kong Sanatorium & Hospital (HKSH) in Hong Kong treated the first cancer patient in Asia using the Radixact® System, the next-generation TomoTherapy®...

Beloved Family Pet's Lung Cancer is Treated with Targeted Radiotherapy Using the Accuray Radixact® System with Synchrony® Technology

SUNNYVALE, Calif., June 24, 2021 /PRNewswire/ -- The University of Wisconsin-Madison (UW-Madison) School of Veterinary Medicine team is advancing cancer care as the first to treat an animal using the Radixact® System with Synchrony®. Accuray (NASDAQ: ARAY) announced today that Mac, a Fox...

Accuray Expands CyberKnife® System Versatility with Integration of RaySearch's RayStation Treatment Planning System

SUNNYVALE, Calif., June 16, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the launch of RayStation* treatment planning support for the company's CyberKnife® M6™** and S7™** Robotic, Radiotherapy Systems. RayStation helps enable clinicians to create treatment...

Accuray Expands Commercialization of ClearRT™ Helical Fan-Beam kVCT Imaging for the Radixact® System with CE Mark Certification

SUNNYVALE, Calif., June 10, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark certification for its ClearRT™ helical fan-beam kVCT imaging capability. The Accuray-only ClearRT technology is now available to customers in the European...

Accuray Announces New $120 Million Credit Facility

SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced it has entered into a new five-year $80 million term loan and $40 million revolving credit facility with Silicon Valley Bank and a syndicate of banks (the "New Credit Facility"). The closing...

Accuray Announces Convertible Notes Exchange and Subscription

SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2022 (the "2022 Notes") to exchange an aggregate of $82.1 million...
Show more

Accuray Frequently Asked Questions

  • When was Accuray founded?

    Accuray was founded in 1990.

  • Who are Accuray key executives?

    Accuray's key executives are Joshua Levine, Suzanne Winter and Shig Hamamatsu.

  • How many employees does Accuray have?

    Accuray has 932 employees.

  • What is Accuray revenue?

    Latest Accuray annual revenue is $382.9 m.

  • What is Accuray revenue per employee?

    Latest Accuray revenue per employee is $410.9 k.

  • Who are Accuray competitors?

    Competitors of Accuray include NovoCure, GenesisCare and Intuitive Surgical.

  • Where is Accuray headquarters?

    Accuray headquarters is located at 1310 Chesapeake Terrace, Sunnyvale.

  • Where are Accuray offices?

    Accuray has offices in Sunnyvale, Madison, Chengdu, Hong Kong and in 2 other locations.

  • How many offices does Accuray have?

    Accuray has 6 offices.